Kevin Kunzmann


Matthew Budoff, MD: Need for Greater Uptake of Newer Medications

September 15, 2021

Matthew Budoff, MD, discusses what he views as hurdles to achieving optimal prescription of newer agents in the treatment of cardiometabolic conditions, including diabetes, heart failure, dyslipidemia, and more.

Why Older Patients Are More At Risk for COVID-19 : A Decline In ACE2 Expression

April 03, 2020

A new perspective from a team of Maryland-based cardiovascular clinicians sheds insight on an often forgotten facet of the inherent COVID-19 risk carried by patients with cardiovascular history: the decline in angiotensin-converting enzyme 2 (ACE2) expression associated with aging, and the response of care most common in such patients.